• Japanese
  • Korean
  • Chinese
Home > Pharmaceutical > Neurodegenerative Disease Market Research Reports
Category
Pharmaceutical (4208)
Cancer (937)
Diabetes (167)
Drug Delivery System (123)
Drug Discovery (1395)
Drug Regulation (108)
Generic Drugs (84)
Infectious Disease (305)
Neurodegenerative Disease (190)
OTC Drug (91)
Pharmaceutical Companies (234)
Prescription Drugs (369)
Vaccines (205)

Neurodegenerative Disease Market Research Reports

We offer reports covering rare and common neurodegenerative diseases such as MS, dementia, Alzheimer’s, and epilepsy. Central nervous system drugs are covered individually in the research, which contains information regarding drug pipelines and R&D challenges, as well as assessments of market potential.

Filter
Title Search
1 - 25 of 190 Products Sort by Display
Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patterns
Product code:297630
Published by GBI Research
Published March 14, 2014 Price USD 3500
Content info 74 Pages
Sample available
Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability
Product code:297629
Published by GBI Research
Published March 14, 2014 Price USD 3500
Content info 66 Pages
Sample available
Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules
Product code:273171
Published by Doctor's Guide Publishing Limited (FirstWord Pharma)
Published March 12, 2014 Price USD 7495
Content info 183 pages
Sample available
*
Product code:297272
Published by China Research and Intelligence
Published March 6, 2014 Price USD 1800
Content info 40 Pages
Sample available
Central Nervous System Partnering Terms and Agreements
Product code:250308
Published by Current Partnering, a division of Wildwood Ventures Limited
Published March 1, 2014 Price USD 2995
Content info 595 Pages
Sample available
Alzheimer's Disease Partnering 2009-2014
Product code:239673
Published by Current Partnering, a division of Wildwood Ventures Limited
Published March 1, 2014 Price USD 1795
Content info  
Sample available
Drug Delivery in Central Nervous System Diseases - technologies, markets and companies
Product code:70934
Published by Jain Pharmabiotech
Published March 1, 2014 Price USD 3000
Content info  
The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders....
*
Product code:70927
Published by Jain Pharmabiotech
Published March 1, 2014 Price USD 4000
Content info  
Alzheimer' s disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable research is in progress to understand the pathomechan...
*
Product code:70919
Published by Jain Pharmabiotech
Published March 1, 2014 Price USD 5000
Content info  
This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders because many of the underlying mechanisms of damage to neural tissues...
Product and Pipeline Analysis of the Global Parkinson's Disease Therapeutics Market
Product code:295018
Published by Frost & Sullivan
Published February 4, 2014 Price USD 4500
Content info 52 Pages
Sample available
Parkinson's Disease: World Drug Industry and Market 2014-2024
Product code:220572
Published by Visiongain
Published February 4, 2014 Price USD 2788
Content info 151 Pages
Sample available
The Parkinson's treatment market has potential to expand. In 2011 there are more than 300 late-stage trials of Parkinson's drugs in progress. Find R&D trends....
PharmaPoint: Crohn's Disease - India Drug Forecast and Market Analysis to 2022
Product code:298499
Published by GlobalData
Published January 31, 2014 Price USD 4995
Content info 79 Pages
Sample available
PharmaPoint: Crohn's Disease - Japan Drug Forecast and Market Analysis to 2022
Product code:298498
Published by GlobalData
Published January 31, 2014 Price USD 4995
Content info 113 Pages
Sample available
PharmaPoint: Crohn's Disease - US Drug Forecast and Market Analysis to 2022
Product code:298497
Published by GlobalData
Published January 31, 2014 Price USD 4995
Content info 138 Pages
Sample available
PharmaPoint: Crohn's Disease - China Drug Forecast and Market Analysis to 2022
Product code:298054
Published by GlobalData
Published January 31, 2014 Price USD 4995
Content info 99 Pages
Sample available
PharmaPoint: Crohn's Disease - 5EU Drug Forecast and Market Analysis to 2022
Product code:298052
Published by GlobalData
Published January 31, 2014 Price USD 4995
Content info 168 Pages
Sample available
PharmaPoint: Crohn's Disease - Global Drug Forecast and Market Analysis to 2022
Product code:298050
Published by GlobalData
Published January 31, 2014 Price USD 9995
Content info 305 Pages
Sample available
Global Amyotrophic Lateral Sclerosis Market 2014-2018
Product code:294972
Published by Infiniti Research Limited (Technavio)
Published January 17, 2014 Price USD 2000
Content info 46 Pages
Sample available
Orphan Drugs for CNS Diseases: R&D and Market 2014-2024
Product code:293356
Published by Visiongain
Published January 10, 2014 Price USD 2788
Content info 130 Pages
Sample available
Parkinson's Disease Therapeutics Market to 2019 - Pipeline Shows Shift Towards Long Term Disease Management
Product code:291996
Published by GBI Research
Published December 15, 2013 Price USD 3500
Content info 130 Pages
Sample available
EpiCast Report: Diabetic Neuropathy - Epidemiology Forecast to 2022
Product code:291029
Published by GlobalData
Published November 30, 2013 Price USD 3995
Content info 45 Pages
Sample available
EpiCast Report: Parkinson's Disease - Epidemiology Forecast to 2022
Product code:290457
Published by GlobalData
Published November 30, 2013 Price USD 3995
Content info 36 Pages
Sample available
Alzheimer's Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation
Product code:290192
Published by GBI Research
Published October 31, 2013 Price USD 3500
Content info 90 Pages
Sample available
Epilepsy Global Clinical Trials Review, H2, 2013
Product code:222283
Published by GlobalData
Published October 14, 2013 Price USD 2500
Content info 140 Pages
Sample available
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts....
Razadyne/Reminyl (Alzheimer's Disease) - Forecast and Market Analysis to 2022
Product code:288603
Published by GlobalData
Published September 30, 2013 Price USD 3495
Content info 63 Pages
Sample available